How much funding has Tenaya Therapeutics raised?

Tenaya Therapeutics has raised $106.0M in total funding, most recently a Series C round.

Who are Tenaya Therapeutics's investors?

Tenaya Therapeutics's investors include Morgan Stanley, Cowen, Piper Sandler.

When was Tenaya Therapeutics founded?

Tenaya Therapeutics was founded in 2016.

Where is Tenaya Therapeutics headquartered?

Tenaya Therapeutics is headquartered in South San Francisco, California, United States.

What industry is Tenaya Therapeutics in?

Tenaya Therapeutics operates in Biotech, Healthcare.

How many employees does Tenaya Therapeutics have?

Tenaya Therapeutics has 51-200 employees.

Tenaya Therapeutics

IPO

Scaling new heights in the fight against heart disease

Public · South San Francisco, United States · Founded 2016 · $106.0M raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 51–200
Founded: 2016
Business Model: B2B
Website: tenayatherapeutics.com

Total Funding: $106.0M
Last Round: $106.0M Series CMar 2021
Rounds: 1
Type: Public

About

Tenaya Therapeutics is a clinical-stage biotechnology company founded by leading cardiovascular scientists to discover, design, develop and deliver potentially curative therapies that address the underlying drivers of heart disease. The company focuses on gene therapy and cellular reprogramming approaches to change the treatment paradigm for patients with serious cardiac conditions.

Summary

Tenaya Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2016. It has raised $106.0M in total across 1 round, most recently a $106.0M Series C round in Mar 2021. Investors include Morgan Stanley, Cowen and Piper Sandler.

LinkedIn X (Twitter)